Browse > Article
http://dx.doi.org/10.3340/jkns.2017.0303.009

Clopidogrel Response Variability in Unruptured Intracranial Aneurysm Patients Treated with Stent-Assisted Endovascular Coil Embolization : Is Follow-Up Clopidogrel Response Test Necessary?  

Kim, Min Soo (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine)
Park, Eun Suk (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine)
Park, Jun Bum (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine)
Lyo, In Uk (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine)
Sim, Hong Bo (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine)
Kwon, Soon Chan (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine)
Publication Information
Journal of Korean Neurosurgical Society / v.61, no.2, 2018 , pp. 201-211 More about this Journal
Abstract
Objective : The purpose of this study was to analyze the variability of clopidogrel responses according to duration of a clopidogrel drug regimen after stent-assisted coil embolization (SAC), and to determine the correlation between the variability of clopidogrel responses and thromboembolic or hemorrhagic complications. Methods : A total of 47 patients who underwent SAC procedures to treat unruptured intracranial aneurysms were enrolled in the study. Preoperatively, patients received more than seven days of aspirin (100 mg) and clopidogrel (75 mg), daily. P2Y12 reaction unit (PRU) was checked with the VerifyNow test one day before the procedure (pre-PRU) and one month after the procedure (post-PRU). PRU variability was calculated as the difference between the initial response and the follow-up response. Patients were sorted into two groups based on their response to treatment : responsive and hypo-responsive. Results : PRU variability was significantly greater in the hypo-responsive group when compared to the responsive group (p=0.019). Pre-PRU and serum platelets counts were significantly correlated with PRU variation (p=0.005 and p=0.004, respectively). Although thromboembolic complication had no significant correlated factors, hemorrhagic complication was correlated with pre-PRU (p=0.033). Conclusion : In conclusion, variability of clopidogrel responses during clopidogrel medication was correlated to serum platelet counts and the initial clopidogrel response. Thromboembolic and hemorrhagic complications did not show correlation with the variability of clopidogrel response, or the clopidogrel response after one month of medication; however, hemorrhagic complication was associated with initial clopidogrel response. Therefore, it is recommended to test patients for an initial clopidogrel response only, as further tests would be insignificant.
Keywords
Intracranial aneurysm; Stents; Thromboembolism; Platelet aggregation inhibitors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Akpek S, Arat A, Morsi H, Klucznick RP, Strother CM, Mawad ME : Selfexpandable stent-assisted coiling of wide-necked intracranial aneurysms: a single-center experience. AJNR Am J Neuroradiol 26 : 1223-1231, 2005
2 Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, et al. : Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler Thromb Vasc Biol 26 : 1895-1900, 2006   DOI
3 Roy D, Milot G, Raymond J : Endovascular treatment of unruptured aneurysms. Stroke 32 : 1998-2004, 2001   DOI
4 Ryu CW, Park S, Shin HS, Koh JS : Complications in stent-assisted endovascular therapy of ruptured intracranial aneurysms and relevance to antiplatelet administration: a systematic review. AJNR Am J Neuroradiol 36 : 1682-1688, 2015   DOI
5 Siasos G, Tousoulis D, Stefanadis C : Multiple mechanisms affect the clopidogrel response. J Am Coll Cardiol 53 : 900-901; author reply 901, 2009
6 Delgado Almandoz JE, Crandall BM, Scholz JM, Fease JL, Anderson RE, Kadkhodayan Y, et al. : Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the pipeline embolization device. J Neurointerv Surg 5 Suppl 3 : iii3- iii10, 2013   DOI
7 Tousoulis D, Siasos G, Zaromitidou M, Oikonomou E, Maniatis K, Kioufis S, et al. : The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. Int J Cardiol 168 : 1594-1596, 2013   DOI
8 Wanke I, Forsting M : Stents for intracranial wide-necked aneurysms: more than mechanical protection. Neuroradiology 50 : 991-998, 2008   DOI
9 Weisz G, Smilowitz NR, Kirtane AJ, Rinaldi MJ, Parvataneni R, Xu K, et al. : Proton pump inhibitors, platelet reactivity, and cardiovascular outcomes after drug-eluting stents in clopidogrel-treated patients: the ADAPT-DES study. Circ Cardiovasc Interv 8 : e001952, 2015
10 Delgado Almandoz JE, Crandall BM, Scholz JM, Fease JL, Anderson RE, Kadkhodayan Y, et al. : Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device. AJNR Am J Neuroradiol 35 : 128-135, 2014   DOI
11 Delgado Almandoz JE, Kadkhodayan Y, Crandall BM, Scholz JM, Fease JL, Tubman DE : Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg 6 : 767-773, 2014   DOI
12 Drazin D, Choulakian A, Nuno M, Kornbluth P, Alexander MJ : Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting. J Neurointerv Surg 3 : 177-181, 2011   DOI
13 Fifi JT, Brockington C, Narang J, Leesch W, Ewing SL, Bennet H, et al. : Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. AJNR Am J Neuroradiol 34 : 716-720, 2013   DOI
14 Geyik S, Yavuz K, Yurttutan N, Saatci I, Cekirge HS : Stent-assisted coiling in endovascular treatment of 500 consecutive cerebral aneurysms with long-term follow-up. AJNR Am J Neuroradiol 34 : 2157-2162, 2013   DOI
15 Brisman JL, Song JK, Newell DW : Cerebral aneurysms. N Engl J Med 355 : 928-939, 2006   DOI
16 Kim MS, Jo KI, Yeon JY, Kim JS, Kim KH, Jeon P, et al. : Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis. Neuroradiology 58 : 1125-1134, 2016   DOI
17 Giustino G, Kirtane AJ, Genereux P, Baber U, Witzenbichler B, Neumann FJ, et al. : Relation between platelet count and platelet reactivity to thrombotic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study. Am J Cardiol 117 : 1703-1713, 2016   DOI
18 Hwang G, Huh W, Lee JS, Villavicencio JB, Villamor RB Jr, Ahn SY, et al. : Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol 72 : 764-772, 2015   DOI
19 Hwang G, Kim JG, Song KS, Lee YJ, Villavicencio JB, Suroto NS, et al. : Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. Radiology 273 : 194-201, 2014   DOI
20 Kim MS, Jo KI, Yeon JY, Kim JS, Kim KH, Jeon P, et al. : Association between postprocedural infarction and antiplatelet drug resistance after coiling for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 37 : 1099-1105, 2016   DOI
21 Maruyama H, Fukuoka T, Deguchi I, Ohe Y, Kato Y, Horiuchi Y, et al. : Response to clopidogrel and its association with chronic kidney disease in noncardiogenic ischemic stroke patients. Intern Med 53 : 215-219, 2014   DOI
22 Pierot L, Wakhloo AK : Endovascular treatment of intracranial aneurysms: current status. Stroke 44 : 2046-2054, 2013   DOI
23 Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. : Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 : 2736-2747, 2011   DOI
24 Mocco J, Fargen KM, Albuquerque FC, Bendok BR, Boulos AS, Carpenter JS, et al. : Delayed thrombosis or stenosis following enterprise-assisted stent-coiling: is it safe? Midterm results of the interstate collaboration of enterprise stent coiling. Neurosurgery 69 : 908-913; discussion 913-914, 2011   DOI
25 Nakagawa I, Park HS, Yokoyama S, Wada T, Hironaka Y, Motoyama Y, et al. : Influence of diabetes mellitus and cigarette smoking on variability of the clopidogrel-induced antiplatelet effect and efficacy of active management of the target P2Y12 reaction unit range in patients undergoing neurointerventional procedures. J Stroke Cerebrovasc Dis 25 : 163-171, 2016   DOI
26 Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, et al. : Concomitant administration of clopidogrel with statins or calciumchannel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). JACC Cardiovasc Interv 6 : 1275-1281, 2013   DOI
27 Oxley TJ, Dowling RJ, Mitchell PJ, Davis S, Yan B : Antiplatelet resistance and thromboembolic complications in neurointerventional procedures. Front Neurol 2 : 83, 2011
28 Park KW, Park JJ, Kang J, Jeon KH, Kang SH, Han JK, et al. : Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI. PLoS One 8 : e52779, 2013   DOI
29 Pierot L, Biondi A : Endovascular techniques for the management of wide-neck intracranial bifurcation aneurysms: a critical review of the literature. J Neuroradiol 43 : 167-175, 2016   DOI
30 Qureshi Z, Hobson AR : Clopidogrel "resistance": where are we now? Cardiovasc Ther 31 : 3-11, 2013   DOI